Zenith Drugs fundamental analysis
ZENITHDRUG
49
0.70 (-1.41%)Last updated on 6 Feb, 2026 | 15:28 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Zenith Drugs Fundamentals
P/E Ratio
8.77
P/B Ratio
0
Div. Yield
0
Sector P/E
66.3
Sector P/B
1.39
Sec. Div. Yield
0.57
Zenith Drugs Fundamentals is currently trading with a P/E Ratio of 8.77, compared to the sector average of 66.3. Its P/B Ratio stands at 0, while the sector’s is 1.39. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.57%.
Zenith Drugs Score Card
Price
Attractive
Growth
Average
Quality
Poor
Management
Poor
On its scorecard, Zenith Drugs reflects: Price – Attractive, Growth – Average, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.
